
|Videos|November 15, 2020
AAO 2020: Medication could reduce burden of steroid drops for patients
Author(s)OT Staff Reports
Cynthia Matossian, MD, FACS, ABES presents the highlights of a poster on outcomes with dexamethasone intraocular suspension 9% and concomitant postoperative anti-inflammatory medications.
Advertisement
Cynthia Matossian, MD, FACES, ABES, of Matossian Eye Associates, presents the highlights of a poster on outcomes with dexamethasone intraocular suspension 9% and concomitant postoperative anti-inflammatory medications.
The study examined early experiences among cataract surgeons with the use of the injectabcle ophthalmic anti-inflammatory medications.
Newsletter
Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
ONL Therapeutics randomizes first European patient in phase 2 GA trial of Xelafaslatide
2
Galimedix Therapeutics earns milestone payment in ophthalmology partnership with Théa Open Innovation
3
Ophthalmic drug shortages more frequent, longer lasting than average
4
Genetic Retinoblastoma Risk Stratified by Age Among Patients with Metachronous Bilateral Conversion
5


































